Estrogens and environmental estrogens

Biomedicine and Pharmacotherapy

Volumn 56, Issue 1, 2002, Pages 36-44

  Tapiero, H ^a   Nguyen Ba, G ^a   Tew, K D ^b  

^a UNIV PARIS SUD   (France)

^b FOX CHASE CANCER CENTER   (United States)

Author keywords

Chemicals; Estrogens; Isoflavones; Lignans; Phytoestrogens

Indexed keywords

1,1,1 TRICHLORO 2 (2 CHLOROPHENYL) 2 (4 CHLOROPHENYL)ETHANE; 4 NONYLPHENOL; BETA HEXACHLOROCYCLOHEXANE; CLOMIFENE; COUMESTROL; DAIDZEIN; DIETHYLSTILBESTROL; ENTERODIOL; ENTEROLACTONE; ESTRADIOL; ESTROGEN; ESTROGEN DERIVATIVE; FORMONONETIN; GENISTEIN; MEDICARPIN; PHYTOESTROGEN; POLYCHLORINATED BIPHENYL DERIVATIVE; ROTENONE; TAMOXIFEN; TOREMIFENE;

CARDIOVASCULAR SYSTEM; DRUG ACCUMULATION; DRUG EFFECT; DRUG METABOLISM; DRUG STABILITY; ESTROGEN ACTIVITY; ESTROGEN SYNTHESIS; FETUS DEVELOPMENT; HUMAN; IMMUNITY; LIPOPHILICITY; LIVER; NONHUMAN; OVARY CYCLE; POSTMENOPAUSE; PREGNANCY; PRIORITY JOURNAL; REVIEW;

EID: 0036178778     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0753-3322(01)00155-X     Document Type: Review

References (115)

1. PCBs as environmental estrogens: Turtle sex determination as a biomarker of environmental contamination
2. Environmental and dietary estrogens and human health
3. Environmental exposures that affect the endocrine system: Public health implications
4. Effects of the β-isomer of hexacholocyclohexane on estrogen-sensitive human mammary tumor cells
5. Novel estrogenic action of the pesticide residue β-hexachlorocyclohexane in human breast cancer cells
6. DDT stimulates c-erbB2, c-met and STATS tyrosine phosphorylation, Grb2-Sos association, MAPK phosphorylation and proliferation of human breast epithelial cells
7. Persistent DDT metabolite p, p'DDE is a potent androgen receptor antagonist
8. Estrogenic activity of some isoflavone derivatives
9. Naturally occurring non-steroidal estrogens of dietary origin
10. Naturally occurring estrogens in foods: A review
11. Phytoestrogens: The biochemistry, physiology and implications for human health of Soy isoflavones
12. Isoflavone: A saponin glucoside in sya
13. Soybean isoflavones, characterization determination and antifungal activity
14. Determination of isoflavones in soybean flours, protein concentrates and isolates
15. Isoflavone content in commercial soybean foods
16. Origin of lignans in mammals and identification of a precursor from plants
17. Discovery and potential clinical importance of mammalian lignans
18. Lignans in man and animal species
19. Flavonoids
20. Molecular basis of agonism and antagonism in the oestrogen receptor
21. Structure of the ligand-binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist
22. Affinity of rabbit uterine estradiol receptor for phytoestrogens and its use in a competitive protein binding radioassay for plasma coumestrol
23. Affinity of phytoestrogen for estradiol-binding proteins and effect of coumestrol on growth of 7,12-dimethylben [a] anthracene induced rat mammary tumors
24. Biochemical targets of the isoflavone genistein in tumor cell lines
25. Dietary soybean may be antiestrogenic in male mice
26. Phytoestrogens are partial estrogen agonists in the adult male mouse
27. Phytoestrogen interaction with estrogen receptors in human breast cancer cells
28. The effect of equol on estrogen receptors and on synthesis of DNA and protein in immature rat uterus
29. Estrogenic potency of genistin and daidzin in mice
30. In vitro bioassays of non-steroidal phytoestrogens
31. In vitro hormonal effects of soybean isoflavones
32. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta
33. Differential ligand activation of estrogen receptors ER and ERβ at AP1 sites
34. Antioxidants isolated from fermented soybeans
35. Inhibition of in vitro microsomal lipid peroxidation by isoflavonoids
36. Antioxidant and antiproliferative effects of the soybean isoflavone genistein
37. Inhibition of UV light- and Fenton reaction-induced oxidative DNA damage by the soybean isoflavone genistein
38. Antioxidant activity of phytoestrogenic isoflavones
39. Genistein, the dietary-derived angiogenesis inhibitor, prevents LDL oxidation and protects endothelial cells from damage by atherogenic LDL
40. Antiproliferative activity of synthetic and naturally occurring flavonoids on tumor cells of the human breast carcinoma cell line ZR-75-1
41. Antiproliferative effects of isoflavones on human cancer cell lines established from the gastrointestinal tract
42. Genistein, a dietary derived inhibitor of angiogenesis
43. Potent inhibitory effects of steroids in an in vitro model of angiogenesis
44. Genistein inhibits both estrogen and growth factor stimulated proliferation of human breast cancer cells
45. Genistein and Biochanin A inhibit the growth of human prostate cancer cells in culture but not epidermal growth factor receptor tyrosine phosphorylation
46. Bone marrow, cytokines and bone remodeling
47. Chemoprevention of breast cancer using tamoxifen
48. Tamoxifen: The herald of a new era of preventive therapeutics
49. The variable metabolic response to dietary isoflavones in humans
50. Postmenopausal estrogen therapy and cardiovascular disease
51. Soy and cholesterol reduction: Clinical experience
52. Depression of plasma cholesterol in men by consumption of baked products containing soy protein
53. Effects of soy isoflavones on atherosclerosis: Potential mechanisms
54. Genistein, daidzein and glycitein inhibit growth and DNA synthesis of aortic smooth muscle cells from stroke-prone spontaneously hypertensive rats
55. Tyrosine phosphorylation of phospholipase C concomitant with its activation by platelet-activating factor in a human B cell line
56. Tyrosine kinase activity in rabbit platelets stimulated with platelets-activating factor. The effect of inhibiting tyrosine kinase with genistein on platelet-signal-molecule elevation and functional responses
57. The effects of genistein on platelet function are due to thromboxane receptor antagonism rather than inhibition of tyrosine kinase
58. Thrombin-induced human platelet aggregation is inhibited by protein tyrosine kinase inhibitors ST 638 and genistein
59. Inhibition of 5α-reductase in genital skin fibroblasts and prostate tissue by dietary lignans and isoflavonoids
60. Estrogen-specific 17β-hydroxysteroid oxidoreductase type 1 (E. C. 1.1.1.62) as a possible target for the action of phytoestrogens
61. A urinary profile study of dietary phytoestrogens: The identification and mode of metabolism of new isoflavonoids
62. Metabolites of dietary (soya) isoflavones in human urine
63. The identification of the weak estrogen equol (7-hydroxy-3-4'-hydroxyphenyl chroman) in human urine
64. Influence of soybean processing, habitual diet and soy dose on urinary isoflavonoid excretion
65. The effective free fraction of estradiol and xenoestrogens in human serum measured by whole cell uptake assays: Physiology of delivery modifies estrogenic activity
66. Dietary isoflavones: Biological effects and relevance to human health
67. Urinary equol excretion with a soy challenge: Influence of habitual diet
68. Steroid UDP glucuronosyl-transferases
69. P450 enzymes of estrogen metabolism
70. Determination of lignans and isoflavonoids in human female plasma following dietary supplementation
71. Quantitative determination of lignans and isoflavones in plasma of omnivorous and vegetarian women by isotope-dilution gas chromatography-mass spectrometry
72. Analysis of plasma isoflavones by reversed phase HPLC-multiple reaction ion monitoring mass spectrometry
73. Soybeans inhibit mammary tumors in model of breast cancer
74. Nonsteroidal estrogens of dietary origin: Possible roles in hormone-dependent disease
75. Western diet and Western diseases: Some hormonal and biochemical mechanisms and associations
76. Molecular effects of genistein on estrogen receptor mediated pathways
77. Estrogenic and antiproliferative properties of genistein and other flavonoids in human breast cancer cells in vitro
78. Genistein a specific inhibitor of tyrosine-specific protein kinases
79. Genistein inhibition of the growth of human breast cancer cells-independence from estrogen receptors and multidrug resistance gene
80. Non-steroidal estrogens of dietary origin: Possible roles in health and disease, metabolism and physiological effects
81. Phytoestrogens: Epidemiology and a possible role in cancer protection
82. Mechanisms of action of the soy isoflavone genistein: Emerging role of its effects through transforming growth factor beta signalling
83. Effects of genistein on the growth and cell cycle progression of normal human lymphocytes and human leukemic MOLT-4 and HL-60 cells
84. Genistein arrests cell cycle progression at G2-M
85. Influence of isoflavones in soy protein isolates on development of induced prostate-related cancers in L-W rats
86. Serine/threonine kinase receptors: Mediators of transforming growth factor beta family signals
87. Alternative mechanisms of action of anti-estrogens
88. Relationship between tamoxifen-induced transforming growth factor Beta 1expression, cytostasis and apoptosis in human breast cancer cells
89. Induction of transforming growth factor beta 1 in human breast cancer in vivo following tamoxifen treatment
90. Tamoxifen induces TGF-beta 1activity and apoptosis of human MCF-7 breast cancer cells in vitro
91. Genistein may inhibit the growth of human mammary epithelial (HME) cells by augmenting transforming growth factor beta (TGFβ) signalling
92. Estrogen promotes apoptosis of murine osteoclasts mediated by TGF beta
93. Soybean isoflavones improve cardiovascular risk factors without affecting the reproductive system of peripubertal rhesus monkeys
94. Postmenopausal estrogen therapy and cardiovascular disease
95. Soy isoflavones enhance coronary vascular reactivity in atherosclerotic female macaque
96. Mechanisms of action of the soy isoflavone genistein: Emerging role of its effects via transforming growth factor β signalling pathways
97. Transcriptional activation of mucin by Pseudomonas aeruginosa lipopolysaccharide in the pathogenesis of cystic fibrosis lung disease
98. Prevention of lipopolysaccharide-induced lethal toxicity by tyrosine kinase inhibitors
99. Effect of genistein on topoisomerase activity and on the growth of [val12] Ha-ras-transformed NIH 3T3 cells
100. Inhibitory effects of the tyrosine kinase inhibitor genistein on mammalian DNA topoisomerase II
101. Genistein suppresses cellular injury following hepatic ischemia/reperfusion
102. Inhibition of UV light -and Fenton reaction-induced oxidative DNA damage by the soybean isoflavone genistein
103. Effects of isoflavones on LDL-cholesterol in vitro but not in vivo
104. Antioxidant properties of dietary phenolic agents in a human LDL oxidation ex vivo model
105. Genistein a dietary ingested isoflavonoid inhibits cell proliferation and in vitro angiogenesis
106. Inhibition of tyrosine protein kinase activity by synthetic isoflavones and flavones
107. Metabolism of the isoflavones genistein and Biochanin A in human breast cancer cell lines
108. The evidence for soybean products as cancer preventive agents
109. Chemopreventive agents: Protease inhibitors
110. Differentiation of soybean antitryptic factors
111. Purification and some properties of a highly active inhibitor of trypsin and chymotrypsin from soybeans
112. Nanomolar concentrations of Bowman-Birk soybean protease inhibitor suppress X-ray induced transformation in vitro
113. Protease inhibitors antagonize the activation of polymorphonuclear leukocyte oxygen consumption
114. 2 formation by activated human polymorphonuclear leukocytes
115. Comparison of the Bowman-Birk protease inhibitor to WR 1065 for protection against radiation induced DNA cellular and tissue damage